Coverage dated December 13, 2021 to December 14, 2021
Pfizer: COVID-19 pill remains effective against severe disease, omicron variant
Headline from FOX 6 Milwaukee
Pfizer said its experimental COVID-19 pill Paxlovid reduced hospitalizations and deaths by 89% among high-risk adults when taken shortly after initial symptoms.
FOX 6 Milwaukee's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Additional data on Pfizer's Covid oral antiviral pill suggests the pill is highly effective. The FDA has not yet scheduled a meeting of its advisory committee to reivew the pill.
Pfizer said Tuesday that clinical trials confirmed its Covid pill -- a new type of treatment that should withstand the mutations seen with the Omicron variant -- drastically reduced hospitalizations…
fizer announced it has shared this latest data with the US Food and Drug Administration as part of its ongoing application for emergency use authorization.
Pfizer said its experimental COVID-19 pill Paxlovid reduced hospitalizations and deaths by 89% among high-risk adults when taken shortly after initial symptoms.
Additional data from Pfizer’s clinical trial of its oral COVID-19 antiviral drug confirm the treatment’s high level of effectiveness, the company said in a news release Tuesday.
President Joe Biden on Tuesday praised Pfizer's report that its experimental treatment for Covid-19 cut the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their first symptoms.
Additional data from Pfizer’s clinical trial of its oral COVID-19 antiviral drug confirm the treatment’s high level of effectiveness, the company said in a news release Tuesday.
By Michael Nedelman, CNN Pfizer’s updated results for its experimental treatment for Covid-19 showed it cut the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their first symptoms, the company announced in a news release Tuesday.
“The protection from hospitalization is obviously fantastic,” said Andrew Pekosz, vice chair of microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health. “That number was a g...
The research finds that the medicine, called Paxlovid, was effective in preventing hospitalization and death when taken by people with mild to moderate illness within a few days of symptoms.
The company said the pill reduced the risk of hospitalization and death by 89 percent if given within three days of the onset of symptoms. It’s been one year since the first vaccine dose in the U.S.
